Web site receives commendation

Dec. 14, 2005
DENTSPLY's www.oraqix.com earns top honors in pharmaceutical category from Web Awards.

DENTSPLY Pharmaceutical has announced that www.oraqix.com has received an "Outstanding Web site" commendation in the pharmaceutical industry category of Web sites from Web Awards.

Imirage, the multimedia firm, who originally developed the web site was recognized by Web Marketing Association, producer of the Web Awards, for their work on www.oraqix.com.

For more information on the Web Awards competition, please visit www.webaward.org.

Oraqix (lidocaine and prilocaine periodontal gel) 2.5%/2.5% is the first FDA approved, needle-free dental local anesthetic indicated for use in adults who require localized anesthesia in periodontal pockets during scaling and/or root planing procedures. Oraqix is NOT for injection.

Oraqix is administered with a unique Oraqix Dispenser. In clinical trials, the most common side effects of Oraqix were application site reaction, headache, and taste perversion.

Oraqix is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any other component of the product.

Oraqix is distributed by OraPharma, Inc. Call (866) 273-7846 for more information or to place an order.